(HMCH) HSBC MSCI China USD - Ratings and Ratios
China Stocks, Equity Funds, Investment Securities, Index Funds, Stocks
Description: HMCH HSBC MSCI China USD
The HSBC MSCI China UCITS ETF USD (HMCH) is an exchange-traded fund that tracks the Morningstar China TME NR USD index, providing exposure to Chinese equities. As a Switzerland-originated ETF, it offers investors a diversified portfolio of Chinese stocks.
With Assets Under Management (AUM) of $906.15 million, HMCH has a substantial presence in the market. To evaluate its performance, key metrics such as tracking error, expense ratio, and trading volume should be considered. A low tracking error indicates that the ETF is effectively replicating the underlying index, while a reasonable expense ratio is crucial for long-term returns. High trading volume typically results in tighter bid-ask spreads, reducing trading costs.
To assess HMCHs investment potential, we can analyze its price movements and volatility. The ETFs current price is $7.63, with a 20-day Simple Moving Average (SMA) of $7.54, indicating a recent uptrend. The 50-day SMA ($7.39) and 200-day SMA ($6.81) also suggest a longer-term bullish trend. The Average True Range (ATR) of 0.07 (0.96%) implies relatively moderate volatility.
From a risk perspective, its essential to examine the ETFs sector allocation, geographic distribution, and market capitalization breakdown. A diversified portfolio with a mix of large-cap, mid-cap, and small-cap stocks can help mitigate risk. Additionally, understanding the ETFs holdings and their respective weightings can provide insights into its overall risk profile and potential areas of concentration.
Additional Sources for HMCH ETF
HMCH ETF Overview
Market Cap in USD | 906m |
Category | China Equity |
TER | 0.28% |
IPO / Inception | 2011-01-26 |
HMCH ETF Ratings
Growth Rating | -13.2 |
Fundamental | - |
Dividend Rating | 16.5 |
Rel. Strength | 17.1 |
Analysts | - |
Fair Price Momentum | 7.52 USD |
Fair Price DCF | - |
HMCH Dividends
Dividend Yield 12m | 2.15% |
Yield on Cost 5y | 1.63% |
Annual Growth 5y | -23.36% |
Payout Consistency | 100.0% |
Payout Ratio | % |
HMCH Growth Ratios
Growth Correlation 3m | 82.2% |
Growth Correlation 12m | 82.1% |
Growth Correlation 5y | -67% |
CAGR 5y | -5.05% |
CAGR/Max DD 5y | -0.08 |
Sharpe Ratio 12m | 0.19 |
Alpha | 17.32 |
Beta | 0.569 |
Volatility | 24.83% |
Current Volume | 1.3k |
Average Volume 20d | 0.6k |
Stop Loss | 7.3 (-4.1%) |
As of July 09, 2025, the stock is trading at USD 7.61 with a total of 1,300 shares traded.
Over the past week, the price has changed by -0.26%, over one month by +0.24%, over three months by +16.16% and over the past year by +34.16%.
Neither. Based on ValueRay´s Analyses, HSBC MSCI China USD is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -13.23 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HMCH is around 7.52 USD . This means that HMCH is currently overvalued and has a potential downside of -1.18%.
HSBC MSCI China USD has no consensus analysts rating.
According to our own proprietary Forecast Model, HMCH HSBC MSCI China USD will be worth about 8.5 in July 2026. The stock is currently trading at 7.61. This means that the stock has a potential upside of +11.7%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 8.5 | 11.7% |